D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Teradyne
TER
$54.8B
| $37.1M | 0.03% |
342,219
-480,813
| -58% | -$45.6M |
|
552
PTC Therapeutics
PTCT
$6.37B
| $37.1M | 0.03% |
1,346,967
+506,158
| +60% | +$11.6M |
|
553
CALL
United Airlines
UAL
$38.4B
| $36.9M | 0.03% |
894,900
+400,800
| +81% | +$15.8M |
|
554
Ollie's Bargain Outlet
OLLI
$4.01B
| $36.9M | 0.03% |
486,430
+264,655
| +119% | +$19.9M |
|
|
WBA
555
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $36.7M | 0.03% |
1,406,100
+623,000
| +80% | +$13.9M |
|
|
ITCI
556
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $36.6M | 0.03% |
511,550
-229,827
| -31% | -$13.2M |
|
|
X
557
PUT
DELISTED
US Steel
X
| $36.3M | 0.03% |
747,000
-398,100
| -35% | -$14.5M |
|
|
RBCP
558
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $36.3M | 0.03% |
280,000
| – | – |
|
559
CALL
American Express
AXP
$223B
| $36M | 0.03% |
192,400
+66,800
| +53% | +$10.8M |
|
560
Moderna
MRNA
$21.5B
| $36M | 0.03% |
362,177
+303,845
| +521% | +$25.6M |
|
561
Marriott Vacations Worldwide
VAC
$3.24B
| $35.9M | 0.03% |
423,408
+260,776
| +160% | +$22.3M |
|
562
CALL
SoFi Technologies
SOFI
$21.1B
| $35.7M | 0.03% |
3,584,800
+332,300
| +10% | +$2.64M |
|
|
MDRX
563
DELISTED
Veradigm Inc. Common Stock
MDRX
| $35.7M | 0.03% |
3,398,754
-235,484
| -6% | -$2.89M |
|
564
PUT
Chewy
CHWY
$8.54B
| $35.6M | 0.03% |
1,504,900
+658,900
| +78% | +$13M |
|
565
Colgate-Palmolive
CL
$72.6B
| $35.4M | 0.03% |
444,709
-515,507
| -54% | -$38.8M |
|
566
CALL
Manulife Financial
MFC
$72.6B
| $35.4M | 0.03% |
1,604,100
+873,900
| +120% | +$16.8M |
|
567
CALL
Synopsys
SNPS
$71.5B
| $35.2M | 0.03% |
68,400
+41,400
| +153% | +$21.2M |
|
568
Outfront Media
OUT
$5.64B
| $34.9M | 0.03% |
2,539,938
+521,474
| +26% | +$5.89M |
|
569
PUT
Costco
COST
$415B
| $34.7M | 0.03% |
52,500
-300
| -0.6% | -$178K |
|
|
TGI
570
DELISTED
Triumph Group
TGI
| $34.5M | 0.03% |
2,082,631
+983,532
| +89% | +$9.97M |
|
571
PUT
Oracle
ORCL
$331B
| $34.5M | 0.03% |
327,100
-297,500
| -48% | -$32.5M |
|
572
Myriad Genetics
MYGN
$530M
| $34.5M | 0.03% |
1,801,306
-376,619
| -17% | -$6.52M |
|
|
NUVL
573
DELISTED
Nuvalent
NUVL
| $34.5M | 0.03% |
468,183
+150,907
| +48% | +$9.34M |
|
574
NETSCOUT
NTCT
$2.86B
| $34.4M | 0.03% |
1,565,484
+321,802
| +26% | +$7.22M |
|
575
Sarepta Therapeutics
SRPT
$1.66B
| $34.3M | 0.03% |
355,533
+263,375
| +286% | +$25.3M |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.